(VIANEWS) – The Innrs Artificial Intelligence algorithm has been making predictions about the next day stock price and guessing some of them correctly.
We, at Via News, will follow this AI algorithm and publish the results every week day.
Yesterday’s AI prediction for today would produce a ROI of -0.84% if an investor was to invest following yesterday’s Innrs AI suggestion.
See the data in the table below.
| Financial Asset | Accuracy | Prediction | ROI |
|---|---|---|---|
| UBS Group (UBS) | 83.93% | $25.65 | 5.7% ✅ |
| Catalent (CTLT) | 83.83% | $47.88 | 4.37% ✅ |
| NewMarket (NEU) | 93.86% | $470.67 | 2.1% ✅ |
| Boston Beer Company (SAM) | 83.26% | $369.35 | 0.69% ✅ |
| Verizon (VZ) | 89.34% | $35.08 | 0.66% ✅ |
| MGM Resorts (MGM) | 83.74% | $44.38 | 0.27% ✅ |
| Ross Stores (ROST) | 88.48% | $124.95 | 0.19% ✅ |
| Air Products and Chemicals (APD) | 83.39% | $302.49 | -0.22% |
| Xerox Corporation (XRX) | 84.28% | $15.62 | -0.51% |
| ONEOK (OKE) | 83.39% | $66.5 | -0.78% |
| Enterprise Products (EPD) | 84.03% | $27.31 | -0.89% |
| Franco (FNV) | 84.16% | $148.51 | -0.97% |
| HCA Holdings (HCA) | 88.83% | $284.28 | -1.14% |
| West Pharmaceutical (WST) | 88.36% | $423.64 | -1.35% |
| Atlassian (TEAM) | 83.72% | $199.64 | -1.41% |
| GlaxoSmithKline (GSK) | 89.23% | $36.28 | -1.51% |
| Rollins (ROL) | 88.27% | $41.41 | -1.67% |
| Hilton Worldwide Holdings (HLT) | 84.5% | $152.85 | -1.76% |
| CarMax (KMX) | 84% | $83.73 | -2.18% |
| Astrazeneca (AZN) | 83.66% | $71.15 | -2.25% |
| Edwards Lifesciences (EW) | 83.39% | $80.34 | -2.25% |
| PT Telekomunikasi (TLK) | 89.1% | $25.46 | -2.88% |
| Banco Santander Brasil (BSBR) | 83.79% | $5.72 | -3.71% |
| ResMed (RMD) | 83.52% | $169.1 | -4.16% |
| Fomento Economico Mexicano S.A.B. de C.V. (FMX) | 83.99% | $120.63 | -5.31% |
1. UBS Group (UBS)
UBS Group has been having an accuracy rate of 83.93% over the last 10 sessions. Previous close price was $25.27 the AI prediction was $25.65 and today’s closing price was $26.71. The intraday ROI for UBS Group (UBS) was 5.7%.
Shares of UBS Group rose by a staggering 23.76% in from $21.42 to $26.51 at 22:29 EST on Thursday, after five consecutive sessions in a row of gains. NYSE is dropping 0.46% to $16,000.37, following the last session’s downward trend.
UBS Group AG provides financial advice and solutions to private, institutional, and corporate clients worldwide.
Earnings Per Share
As for profitability, UBS Group has a trailing twelve months EPS of $1.96.
PE Ratio
UBS Group has a trailing twelve months price to earnings ratio of 13.52. Meaning, the purchaser of the share is investing $13.52 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.27%.
More news about UBS Group.
2. Catalent (CTLT)
Catalent has been having an accuracy rate of 83.83% over the last 10 sessions. Previous close price was $47.88 the AI prediction was $47.88 and today’s closing price was $49.97. The intraday ROI for Catalent (CTLT) was 4.37%.
Shares of Catalent rose 6.82% in from $46.95 to $50.15 at 22:29 EST on Thursday, after five successive sessions in a row of gains. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide.
Earnings Per Share
As for profitability, Catalent has a trailing twelve months EPS of $0.24.
PE Ratio
Catalent has a trailing twelve months price to earnings ratio of 208.96. Meaning, the purchaser of the share is investing $208.96 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.47%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Catalent’s stock is considered to be oversold (<=20).
Moving Average
Catalent’s worth is way above its 50-day moving average of $45.43 and above its 200-day moving average of $50.13.
Previous days news about Catalent
- Catalent (ctlt) gains post deal with elliott and earnings report. According to Zacks on Wednesday, 30 August, "Per the agreement, Catalent needs to engage in transactions that would make Elliott own more than 10% of the company’s common stock, or increase its economic exposure to more than 14.9% of its common stock."
- Compared to estimates, catalent (ctlt) Q4 earnings: A look at key metrics. According to Zacks on Thursday, 31 August, "Here is how Catalent performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:"
More news about Catalent.
3. NewMarket (NEU)
NewMarket has been having an accuracy rate of 93.86% over the last 10 sessions. Previous close price was $459.99 the AI prediction was $470.67 and today’s closing price was $469.64. The intraday ROI for NewMarket (NEU) was 2.1%.
Shares of NewMarket jumped 2.2% in from $458.03 to $468.11 at 22:29 EST on Thursday, after four successive sessions in a row of gains. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
NewMarket Corporation, through its subsidiaries, primarily engages in the manufacture and sale of petroleum additives.
Earnings Per Share
As for profitability, NewMarket has a trailing twelve months EPS of $35.92.
PE Ratio
NewMarket has a trailing twelve months price to earnings ratio of 13.03. Meaning, the purchaser of the share is investing $13.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 43.49%.
Yearly Top and Bottom Value
NewMarket’s stock is valued at $468.11 at 22:29 EST, below its 52-week high of $471.66 and way higher than its 52-week low of $280.28.
Revenue Growth
Year-on-year quarterly revenue growth declined by 5.3%, now sitting on 2.77B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
NewMarket’s EBITDA is 1.88.
More news about NewMarket.
4. Boston Beer Company (SAM)
Boston Beer Company has been having an accuracy rate of 83.26% over the last 10 sessions. Previous close price was $362.91 the AI prediction was $369.35 and today’s closing price was $365.43. The intraday ROI for Boston Beer Company (SAM) was 0.69%.
Shares of Boston Beer Company jumped 1.02% in from $359.21 to $362.87 at 22:29 EST on Thursday, after four consecutive sessions in a row of gains. NYSE is dropping 0.46% to $16,000.37, following the last session’s downward trend.
The Boston Beer Company, Inc. engages in the production and sale of alcohol beverages primarily in the United States.
Earnings Per Share
As for profitability, Boston Beer Company has a trailing twelve months EPS of $5.31.
PE Ratio
Boston Beer Company has a trailing twelve months price to earnings ratio of 68.34. Meaning, the purchaser of the share is investing $68.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.09%.
Volume
Today’s last reported volume for Boston Beer Company is 9468 which is 92.67% below its average volume of 129220.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Boston Beer Company’s EBITDA is 2.04.
Yearly Top and Bottom Value
Boston Beer Company’s stock is valued at $362.87 at 22:29 EST, way below its 52-week high of $422.75 and way above its 52-week low of $296.27.
More news about Boston Beer Company.
5. Verizon (VZ)
Verizon has been having an accuracy rate of 89.34% over the last 10 sessions. Previous close price was $34.75 the AI prediction was $35.08 and today’s closing price was $34.98. The intraday ROI for Verizon (VZ) was 0.66%.
Shares of Verizon jumped 4.74% in from $33.3 to $34.88 at 22:29 EST on Thursday, after two sequential sessions in a row of gains. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
Verizon Communications Inc., through its subsidiaries, provides communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide.
Earnings Per Share
As for profitability, Verizon has a trailing twelve months EPS of $5.
PE Ratio
Verizon has a trailing twelve months price to earnings ratio of 6.98. Meaning, the purchaser of the share is investing $6.98 for every dollar of annual earnings.
Volatility
Verizon’s last week, last month’s, and last quarter’s current intraday variation average was 1.42%, 0.16%, and 1.08%.
Verizon’s highest amplitude of average volatility was 1.54% (last week), 0.66% (last month), and 1.08% (last quarter).
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Verizon’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for Verizon is 3682480 which is 85.3% below its average volume of 25057300.
More news about Verizon.
6. MGM Resorts (MGM)
MGM Resorts has been having an accuracy rate of 83.74% over the last 10 sessions. Previous close price was $43.86 the AI prediction was $44.38 and today’s closing price was $43.98. The intraday ROI for MGM Resorts (MGM) was 0.27%.
Shares of MGM Resorts fell by a staggering 11.87% in from $50.09 to $44.14 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is dropping 0.46% to $16,000.37, following the last session’s downward trend.
MGM Resorts International, through its subsidiaries, owns and operates casino, hotel, and entertainment resorts in the United States and Macau.
Earnings Per Share
As for profitability, MGM Resorts has a trailing twelve months EPS of $1.27.
PE Ratio
MGM Resorts has a trailing twelve months price to earnings ratio of 34.76. Meaning, the purchaser of the share is investing $34.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -10.79%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MGM Resorts’s EBITDA is 2.89.
Moving Average
MGM Resorts’s worth is below its 50-day moving average of $45.53 and above its 200-day moving average of $41.77.
More news about MGM Resorts.
7. Ross Stores (ROST)
Ross Stores has been having an accuracy rate of 88.48% over the last 10 sessions. Previous close price was $121.58 the AI prediction was $124.95 and today’s closing price was $121.81. The intraday ROI for Ross Stores (ROST) was 0.19%.
Shares of Ross Stores jumped 9.16% in from $111.81 to $122.05 at 22:29 EST on Thursday, after five consecutive sessions in a row of gains. NASDAQ is rising 0.11% to $14,034.97, after five sequential sessions in a row of gains.
Ross Stores, Inc., together with its subsidiaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dd's DISCOUNTS brand names in the United States.
Earnings Per Share
As for profitability, Ross Stores has a trailing twelve months EPS of $4.71.
PE Ratio
Ross Stores has a trailing twelve months price to earnings ratio of 25.91. Meaning, the purchaser of the share is investing $25.91 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 37.44%.
More news about Ross Stores.
8. Air Products and Chemicals (APD)
Air Products and Chemicals has been having an accuracy rate of 83.39% over the last 10 sessions. Previous close price was $296.14 the AI prediction was $302.49 and today’s closing price was $295.49. The intraday ROI for Air Products and Chemicals (APD) was -0.22%.
Shares of Air Products and Chemicals slid 1.15% in from $299.98 to $296.53 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
Air Products and Chemicals, Inc. provides atmospheric gases, process and specialty gases, equipment, and related services in the Americas, Asia, Europe, the Middle East, India, and internationally.
Earnings Per Share
As for profitability, Air Products and Chemicals has a trailing twelve months EPS of $9.78.
PE Ratio
Air Products and Chemicals has a trailing twelve months price to earnings ratio of 30.32. Meaning, the purchaser of the share is investing $30.32 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.04%.
Volume
Today’s last reported volume for Air Products and Chemicals is 109880 which is 85.92% below its average volume of 780690.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Air Products and Chemicals’s stock is considered to be oversold (<=20).
More news about Air Products and Chemicals.
9. Xerox Corporation (XRX)
Xerox Corporation has been having an accuracy rate of 84.28% over the last 10 sessions. Previous close price was $15.81 the AI prediction was $15.62 and today’s closing price was $15.89. The intraday ROI for Xerox Corporation (XRX) was -0.51%.
Shares of Xerox Corporation jumped 2.22% in from $15.78 to $16.13 at 22:29 EST on Thursday, after two sequential sessions in a row of gains. NYSE is sliding 0.46% to $16,000.37, following the last session’s downward trend.
Xerox Holdings Corporation, a workplace technology company, designs, develops, and sells document management systems and solutions in the Americas, Europe, the Middle East, Africa, India, and internationally.
Earnings Per Share
As for profitability, Xerox Corporation has a trailing twelve months EPS of $-1.71.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.79%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Xerox Corporation’s stock is considered to be overbought (>=80).
Volume
Today’s last reported volume for Xerox Corporation is 166564 which is 88.42% below its average volume of 1438940.
Sales Growth
Xerox Corporation’s sales growth is negative 1% for the current quarter and negative 4.1% for the next.
Yearly Top and Bottom Value
Xerox Corporation’s stock is valued at $16.13 at 22:29 EST, way under its 52-week high of $19.40 and way above its 52-week low of $11.80.
More news about Xerox Corporation.
10. ONEOK (OKE)
ONEOK has been having an accuracy rate of 83.39% over the last 10 sessions. Previous close price was $65.71 the AI prediction was $66.5 and today’s closing price was $65.2. The intraday ROI for ONEOK (OKE) was -0.78%.
Shares of ONEOK jumped 0.41% in from $65.3 to $65.57 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
ONEOK, Inc., together with its subsidiaries, engages in gathering, processing, fractionation, storage, transportation, and marketing of natural gas and natural gas liquids (NGL) in the United States.
Earnings Per Share
As for profitability, ONEOK has a trailing twelve months EPS of $5.42.
PE Ratio
ONEOK has a trailing twelve months price to earnings ratio of 12.1. Meaning, the purchaser of the share is investing $12.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.52%.
Yearly Top and Bottom Value
ONEOK’s stock is valued at $65.57 at 22:29 EST, below its 52-week high of $71.57 and way above its 52-week low of $50.50.
Sales Growth
ONEOK’s sales growth is negative 27.5% for the current quarter and negative 4.9% for the next.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ONEOK’s EBITDA is 2.18.
Revenue Growth
Year-on-year quarterly revenue growth declined by 37.8%, now sitting on 19.2B for the twelve trailing months.
More news about ONEOK.
11. Enterprise Products (EPD)
Enterprise Products has been having an accuracy rate of 84.03% over the last 10 sessions. Previous close price was $26.85 the AI prediction was $27.31 and today’s closing price was $26.61. The intraday ROI for Enterprise Products (EPD) was -0.89%.
Shares of Enterprise Products rose 0.38% in from $26.58 to $26.68 at 22:29 EST on Thursday, after two successive sessions in a row of losses. NYSE is dropping 0.46% to $16,000.37, following the last session’s downward trend.
Enterprise Products Partners L.P. provides midstream energy services to producers and consumers of natural gas, natural gas liquids (NGLs), crude oil, petrochemicals, and refined products.
Earnings Per Share
As for profitability, Enterprise Products has a trailing twelve months EPS of $2.47.
PE Ratio
Enterprise Products has a trailing twelve months price to earnings ratio of 10.8. Meaning, the purchaser of the share is investing $10.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.14%.
Moving Average
Enterprise Products’s worth is above its 50-day moving average of $26.52 and higher than its 200-day moving average of $25.77.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Enterprise Products’s EBITDA is 1.64.
Sales Growth
Enterprise Products’s sales growth is negative 16.3% for the ongoing quarter and negative 8% for the next.
Volatility
Enterprise Products’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.28%, a negative 0.02%, and a positive 0.52%.
Enterprise Products’s highest amplitude of average volatility was 0.65% (last week), 0.48% (last month), and 0.52% (last quarter).
More news about Enterprise Products.
12. Franco (FNV)
Franco has been having an accuracy rate of 84.16% over the last 10 sessions. Previous close price was $145.37 the AI prediction was $148.51 and today’s closing price was $143.96. The intraday ROI for Franco (FNV) was -0.97%.
Shares of Franco rose 3.1% in from $139.12 to $143.43 at 22:29 EST on Thursday, after two consecutive sessions in a row of losses. NYSE is sliding 0.46% to $16,000.37, following the last session’s downward trend.
Franco-Nevada Corporation operates as a gold-focused royalty and streaming company in Latin America, the United States, Canada, and internationally.
Earnings Per Share
As for profitability, Franco has a trailing twelve months EPS of $3.45.
PE Ratio
Franco has a trailing twelve months price to earnings ratio of 41.58. Meaning, the purchaser of the share is investing $41.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.28%.
More news about Franco.
13. HCA Holdings (HCA)
HCA Holdings has been having an accuracy rate of 88.83% over the last 10 sessions. Previous close price was $280.49 the AI prediction was $284.28 and today’s closing price was $277.3. The intraday ROI for HCA Holdings (HCA) was -1.14%.
Shares of HCA Holdings rose 3.84% in from $269.34 to $279.68 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States.
Earnings Per Share
As for profitability, HCA Holdings has a trailing twelve months EPS of $20.23.
PE Ratio
HCA Holdings has a trailing twelve months price to earnings ratio of 13.83. Meaning, the purchaser of the share is investing $13.83 for every dollar of annual earnings.
Volatility
HCA Holdings’s last week, last month’s, and last quarter’s current intraday variation average was 0.37%, 0.06%, and 0.90%.
HCA Holdings’s highest amplitude of average volatility was 0.81% (last week), 0.92% (last month), and 0.90% (last quarter).
More news about HCA Holdings.
14. West Pharmaceutical (WST)
West Pharmaceutical has been having an accuracy rate of 88.36% over the last 10 sessions. Previous close price was $412.48 the AI prediction was $423.64 and today’s closing price was $406.9. The intraday ROI for West Pharmaceutical (WST) was -1.35%.
Shares of West Pharmaceutical jumped by a staggering 10.77% in from $370.37 to $410.26 at 22:29 EST on Thursday, after four consecutive sessions in a row of losses. NYSE is sliding 0.46% to $16,000.37, following the last session’s downward trend.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Earnings Per Share
As for profitability, West Pharmaceutical has a trailing twelve months EPS of $6.89.
PE Ratio
West Pharmaceutical has a trailing twelve months price to earnings ratio of 59.54. Meaning, the purchaser of the share is investing $59.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.06%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
West Pharmaceutical’s EBITDA is 9.98.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jul 24, 2023, the estimated forward annual dividend rate is 0.76 and the estimated forward annual dividend yield is 0.19%.
Moving Average
West Pharmaceutical’s worth is higher than its 50-day moving average of $379.95 and way higher than its 200-day moving average of $319.44.
More news about West Pharmaceutical.
15. Atlassian (TEAM)
Atlassian has been having an accuracy rate of 83.72% over the last 10 sessions. Previous close price was $201.23 the AI prediction was $199.64 and today’s closing price was $204.06. The intraday ROI for Atlassian (TEAM) was -1.41%.
Shares of Atlassian rose by a staggering 19.93% in from $170.72 to $204.74 at 22:29 EST on Thursday, after five successive sessions in a row of gains. NASDAQ is rising 0.11% to $14,034.97, after five successive sessions in a row of gains.
Atlassian Corporation, through its subsidiaries, designs, develops, licenses, and maintains various software products worldwide.
Earnings Per Share
As for profitability, Atlassian has a trailing twelve months EPS of $-1.97.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -99.13%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.6%, now sitting on 3.53B for the twelve trailing months.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Atlassian’s EBITDA is 13.67.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Atlassian’s stock is considered to be oversold (<=20).
Yearly Top and Bottom Value
Atlassian’s stock is valued at $204.74 at 22:29 EST, way under its 52-week high of $264.97 and way higher than its 52-week low of $113.86.
More news about Atlassian.
16. GlaxoSmithKline (GSK)
GlaxoSmithKline has been having an accuracy rate of 89.23% over the last 10 sessions. Previous close price was $35.67 the AI prediction was $36.28 and today’s closing price was $35.13. The intraday ROI for GlaxoSmithKline (GSK) was -1.51%.
Shares of GlaxoSmithKline jumped 1.96% in from $34.67 to $35.35 at 22:29 EST on Thursday, after two successive sessions in a row of losses. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $3.19.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 11.08. Meaning, the purchaser of the share is investing $11.08 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.22%.
More news about GlaxoSmithKline.
17. Rollins (ROL)
Rollins has been having an accuracy rate of 88.27% over the last 10 sessions. Previous close price was $40.24 the AI prediction was $41.41 and today’s closing price was $39.57. The intraday ROI for Rollins (ROL) was -1.67%.
Shares of Rollins slid 3.87% in from $41.39 to $39.79 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
Rollins, Inc., through its subsidiaries, provides pest and wildlife control services to residential and commercial customers in the United States and internationally.
Earnings Per Share
As for profitability, Rollins has a trailing twelve months EPS of $0.79.
PE Ratio
Rollins has a trailing twelve months price to earnings ratio of 50.37. Meaning, the purchaser of the share is investing $50.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.48%.
Sales Growth
Rollins’s sales growth is 15.7% for the present quarter and 12.2% for the next.
Volume
Today’s last reported volume for Rollins is 236521 which is 82.91% below its average volume of 1384120.
More news about Rollins.
18. Hilton Worldwide Holdings (HLT)
Hilton Worldwide Holdings has been having an accuracy rate of 84.5% over the last 10 sessions. Previous close price was $151.31 the AI prediction was $152.85 and today’s closing price was $148.65. The intraday ROI for Hilton Worldwide Holdings (HLT) was -1.76%.
Shares of Hilton Worldwide Holdings fell 3.15% in from $153.63 to $148.79 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
Hilton Worldwide Holdings Inc., a hospitality company, engages in managing, franchising, owning, and leasing hotels and resorts.
Earnings Per Share
As for profitability, Hilton Worldwide Holdings has a trailing twelve months EPS of $4.76.
PE Ratio
Hilton Worldwide Holdings has a trailing twelve months price to earnings ratio of 31.26. Meaning, the purchaser of the share is investing $31.26 for every dollar of annual earnings.
Volume
Today’s last reported volume for Hilton Worldwide Holdings is 211000 which is 87.69% below its average volume of 1714820.
Volatility
Hilton Worldwide Holdings’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.28%, a negative 0.18%, and a positive 0.98%.
Hilton Worldwide Holdings’s highest amplitude of average volatility was 0.87% (last week), 0.82% (last month), and 0.98% (last quarter).
More news about Hilton Worldwide Holdings.
19. CarMax (KMX)
CarMax has been having an accuracy rate of 84% over the last 10 sessions. Previous close price was $83.5 the AI prediction was $83.73 and today’s closing price was $81.68. The intraday ROI for CarMax (KMX) was -2.18%.
Shares of CarMax dropped 1.44% in from $82.9 to $81.71 at 22:29 EST on Thursday, following the last session’s downward trend. NYSE is sliding 0.46% to $16,000.37, following the last session’s downward trend.
CarMax, Inc., together with its subsidiaries, operates as a retailer of used vehicles in the United States.
Earnings Per Share
As for profitability, CarMax has a trailing twelve months EPS of $2.97.
PE Ratio
CarMax has a trailing twelve months price to earnings ratio of 27.51. Meaning, the purchaser of the share is investing $27.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.21%.
More news about CarMax.
20. Astrazeneca (AZN)
Astrazeneca has been having an accuracy rate of 83.66% over the last 10 sessions. Previous close price was $69.38 the AI prediction was $71.15 and today’s closing price was $67.82. The intraday ROI for Astrazeneca (AZN) was -2.25%.
Shares of Astrazeneca slid 3.01% in from $70.63 to $68.50 at 22:29 EST on Thursday, after two sequential sessions in a row of losses. NYSE is sliding 0.46% to $16,000.37, following the last session’s downward trend.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
Earnings Per Share
As for profitability, Astrazeneca has a trailing twelve months EPS of $1.98.
PE Ratio
Astrazeneca has a trailing twelve months price to earnings ratio of 34.6. Meaning, the purchaser of the share is investing $34.6 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.82%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Aug 9, 2023, the estimated forward annual dividend rate is 1.45 and the estimated forward annual dividend yield is 2.12%.
Moving Average
Astrazeneca’s value is below its 50-day moving average of $69.52 and under its 200-day moving average of $69.41.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 7.1% and 34.8%, respectively.
More news about Astrazeneca.
21. Edwards Lifesciences (EW)
Edwards Lifesciences has been having an accuracy rate of 83.39% over the last 10 sessions. Previous close price was $78.23 the AI prediction was $80.34 and today’s closing price was $76.47. The intraday ROI for Edwards Lifesciences (EW) was -2.25%.
Shares of Edwards Lifesciences slid 4.11% in from $80.89 to $77.57 at 22:29 EST on Thursday, after two successive sessions in a row of losses. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally.
Earnings Per Share
As for profitability, Edwards Lifesciences has a trailing twelve months EPS of $2.31.
PE Ratio
Edwards Lifesciences has a trailing twelve months price to earnings ratio of 33.58. Meaning, the purchaser of the share is investing $33.58 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.4%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Edwards Lifesciences’s stock is considered to be oversold (<=20).
Sales Growth
Edwards Lifesciences’s sales growth is 12.2% for the present quarter and 13.9% for the next.
More news about Edwards Lifesciences.
22. PT Telekomunikasi (TLK)
PT Telekomunikasi has been having an accuracy rate of 89.1% over the last 10 sessions. Previous close price was $24.99 the AI prediction was $25.46 and today’s closing price was $24.27. The intraday ROI for PT Telekomunikasi (TLK) was -2.88%.
Shares of PT Telekomunikasi jumped 1.71% in from $24.02 to $24.43 at 22:29 EST on Thursday, after two sequential sessions in a row of losses. NYSE is dropping 0.46% to $16,000.37, following the last session’s downward trend.
Perusahaan Perseroan (Persero) PT Telekomunikasi Indonesia Tbk provides information and communications technology, and telecommunications network services worldwide.
Earnings Per Share
As for profitability, PT Telekomunikasi has a trailing twelve months EPS of $1.33.
PE Ratio
PT Telekomunikasi has a trailing twelve months price to earnings ratio of 18.37. Meaning, the purchaser of the share is investing $18.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.18%.
Yearly Top and Bottom Value
PT Telekomunikasi’s stock is valued at $24.43 at 22:29 EST, way under its 52-week high of $30.76 and above its 52-week low of $23.03.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, PT Telekomunikasi’s stock is considered to be oversold (<=20).
Volume
Today’s last reported volume for PT Telekomunikasi is 43243 which is 76.77% below its average volume of 186219.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jun 13, 2023, the estimated forward annual dividend rate is 1.13 and the estimated forward annual dividend yield is 4.63%.
More news about PT Telekomunikasi.
23. Banco Santander Brasil (BSBR)
Banco Santander Brasil has been having an accuracy rate of 83.79% over the last 10 sessions. Previous close price was $5.66 the AI prediction was $5.72 and today’s closing price was $5.45. The intraday ROI for Banco Santander Brasil (BSBR) was -3.71%.
Shares of Banco Santander Brasil dropped 8.49% in from $5.92 to $5.42 at 22:29 EST on Thursday, after two consecutive sessions in a row of losses. NYSE is dropping 0.46% to $16,000.37, following the last session’s downward trend.
Banco Santander (Brasil) S.A., together with its subsidiaries, provides various banking products and services to individuals, small and medium enterprises, and corporate customers in Brazil and internationally.
Earnings Per Share
As for profitability, Banco Santander Brasil has a trailing twelve months EPS of $0.28.
PE Ratio
Banco Santander Brasil has a trailing twelve months price to earnings ratio of 19.36. Meaning, the purchaser of the share is investing $19.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.93%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Apr 24, 2023, the estimated forward annual dividend rate is 0.34 and the estimated forward annual dividend yield is 6.28%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Banco Santander Brasil’s stock is considered to be overbought (>=80).
More news about Banco Santander Brasil.
24. ResMed (RMD)
ResMed has been having an accuracy rate of 83.52% over the last 10 sessions. Previous close price was $166.51 the AI prediction was $169.1 and today’s closing price was $159.59. The intraday ROI for ResMed (RMD) was -4.16%.
Shares of ResMed slid by a staggering 36.54% in from $256.32 to $162.66 at 22:29 EST on Thursday, after two consecutive sessions in a row of losses. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
Earnings Per Share
As for profitability, ResMed has a trailing twelve months EPS of $6.1.
PE Ratio
ResMed has a trailing twelve months price to earnings ratio of 26.67. Meaning, the purchaser of the share is investing $26.67 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.96%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ResMed’s EBITDA is 5.93.
Moving Average
ResMed’s value is way below its 50-day moving average of $203.73 and way under its 200-day moving average of $215.92.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ResMed’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 7.9% and 4.8%, respectively.
More news about ResMed.
25. Fomento Economico Mexicano S.A.B. de C.V. (FMX)
Fomento Economico Mexicano S.A.B. de C.V. has been having an accuracy rate of 83.99% over the last 10 sessions. Previous close price was $118.83 the AI prediction was $120.63 and today’s closing price was $112.52. The intraday ROI for Fomento Economico Mexicano S.A.B. de C.V. (FMX) was -5.31%.
Shares of Fomento Economico Mexicano S.A.B. de C.V. rose 4.88% in from $110.41 to $115.80 at 22:29 EST on Thursday, after four successive sessions in a row of losses. NYSE is falling 0.46% to $16,000.37, following the last session’s downward trend.
Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages.
Earnings Per Share
As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $3.88.
PE Ratio
Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 29.85. Meaning, the purchaser of the share is investing $29.85 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.28%.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on May 3, 2023, the estimated forward annual dividend rate is 1.9 and the estimated forward annual dividend yield is 1.65%.
Moving Average
Fomento Economico Mexicano S.A.B. de C.V.’s value is above its 50-day moving average of $111.16 and way above its 200-day moving average of $94.47.
More news about Fomento Economico Mexicano S.A.B. de C.V..
